Publication: 3531

Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC
      QxMD      Google Scholar   
Citation:
JTO Clin Res Rep vol 2 (8)
Year:
2021
Type:
Manuscript
Funding:
AFT
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub-ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
11
Parents:
3081  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
Merck  
Grants:
 
Corr. Author:
 
Authors:
                           
Networks:
HEARTLAND, IL018, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC010, LAPS-NH012, LAPS-OH007, NY141   
Study
AFT-09
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: